Skip to content
★ Sign in to follow
Tibet Weixinkang Medicine Co., Ltd. logo

Tibet Weixinkang Medicine Co., Ltd. Stock: price and insider trades · China

卫信康

CN·Mcap CN¥3.8BHealth Care

Tibet Weixinkang Medicine Co., Ltd.: what insiders have been doing

Tibet Weixinkang Medicine Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). No insider at Tibet Weixinkang Medicine Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 3 February 2023.

Our records for Tibet Weixinkang Medicine Co., Ltd. go back to 2022, with no purchases and 8 sales on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€559,418
8 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 4,019 of 26,911 companies
70.3
score / 100
Value
57
Quality
84
FCF yld2.7%
Earn yld6.1%
EV/EBITDA11.4x
ROE13%
Gross mgn61%
Net mgn21%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥8.77
Analyst consensus
·
Income statement
RevenueCN¥1.1B
Gross profitCN¥697.9M61% margin
EBITDACN¥334.7M29% margin
Net incomeCN¥232.9M17.0% margin
Valuation
PER (trailing)19.5x
P/Book2.5x
Beta-0.08
Balance sheet & cash
Market capCN¥3.8B
Total debtCN¥11.2M
Free Cash FlowCN¥101.6M
Debt / Equity1%
Profitability & ownership
ROE12.7%
ROA5.0%
% insiders78.0%
% institutions0.5%
Last declaration on 3 February 2023
Declarations8 total
  • ▼
    高级管理人员Executives
    645,456 CNY16SSE
    42,000 shares48.3% of flowA股XSHGSSE:173000006252881180
  • ▼
    高级管理人员Executives
    125,034 CNY12SSE
    7,800 shares9.4% of flowA股XSHGSSE:173000006248457900
  • ▼
    高级管理人员Executives
    569,200 CNY15SSE
    40,000 shares42.2% of flowA股XSHGSSE:173000006163705150
  • ▼
    高级管理人员Executives
    1,410 CNY11SSE
    100 shares0.1% of flowA股XSHGSSE:173000006159161120
  • ▼
    董事,高级管理人员Executives
    344,000 CNY27SSE
    20,000 shares100.0% of flowA股XSHGSSE:173000006060669470
  • ▼
    高级管理人员Executives
    1M CNY16SSE
    75,000 shares49.7% of flowA股XSHGSSE:173000006041313120
  • ▼
    高级管理人员Executives
    46,080 CNY11SSE
    3,000 shares1.9% of flowA股XSHGSSE:173000005999951140
  • ▼
    高级管理人员Executives
    1M CNY16SSE
    71,800 shares48.4% of flowA股XSHGSSE:173000005992429200

8 of 8 declarations

About Tibet Weixinkang Medicine Co., Ltd.

卫信康 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative health solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations